HRT Financial
MIST icon

HRT Financial’s Milestone Pharmaceuticals MIST Stock Holding History

HRT Financial’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,256
Closed -$74K – 4910
2026
Q1 		$74K Buy
+62,256
New +$109K ﹤0.01% 3402
2025
Q4 		– Sell
-138,812
Closed -$277K – 3693
2025
Q3 		$277K Buy
+138,812
New +$244K ﹤0.01% 2220

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

HRT Financial's MIST Position: Q2 2026 in Review

HRT Financial sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 62,256 shares — an estimated $74K sold.

HRT Financial first reported a position in MIST in Q3 2025 and held it in 2 quarters. The position peaked at $277K in Q3 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • HRT Financial reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 62,256 Milestone Pharmaceuticals shares in Q2 2026, an estimated $74K.
  • HRT Financial first reported a position in Milestone Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • HRT Financial's Milestone Pharmaceuticals position peaked at $277K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.